GlassScriptPhysician profile
Mahwash Kassi
NPI 1497034789
$23,305.29
in general payments reported to CMS, 2019-2025
25 companies · $10K in 2025
The $10K reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,486 · 2020: $224 · 2021: $949 · 2022: $2,016 · 2023: $2,920 · 2024: $5,633 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $4,275 · Travel and Lodging: $1,871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,485.00 |
| Food and Beverage | $4,275.23 |
| Travel and Lodging | $1,870.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $7,375.61 | 2024-2025 | |
| Bridgebio Pharma, INC. | $4,364.21 | 2025 | Attruby |
| Abbott Laboratories | $3,849.46 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, 2nd Gen Centrimag Primary Console |
| Abiomed | $3,044.94 | 2019-2025 | Impella |
| Pfizer INC. | $1,818.43 | 2021-2025 | |
| Alnylam Pharmaceuticals INC. | $913.65 | 2020-2025 | Amvuttra, Onpattro |
| Atricure, INC. | $323.53 | 2022-2023 | |
| Medtronic, INC. | $288.52 | 2023-2025 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan, Attain Command + Surevalve |
| Impulse Dynamics (USA) INC. | $234.45 | 2021-2024 | Optimizer, Optimizer |
| Actelion Pharmaceuticals US, INC. | $209.77 | 2020-2024 | Uptravi, Opsumit |
| Amgen INC. | $191.81 | 2019-2024 | Repatha |
| Medtronic Vascular, INC. | $187.13 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.43 | 2022-2025 | Jardiance |
| Siemens Medical Solutions USA, INC. | $64.20 | 2019-2025 | Syngo Dynamics |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $63.29 | 2024 | Lifevest |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $49.49 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $47.28 | 2023-2024 | Inpefa |
| Tactile Systems Technology INC | $44.29 | 2021-2024 | Entre Plus, Flexitouch Plus |
| Astrazeneca Pharmaceuticals LP | $42.32 | 2021-2025 | Wainua |
| Takeda Pharmaceuticals U.S.A., INC. | $24.79 | 2025 | Livtencity |
| Haemonetics Corporation | $23.60 | 2019 | |
| Scpharmaceuticals INC. | $19.65 | 2024 | |
| Novo Nordisk INC | $18.44 | 2025 | Wegovy |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahwash Kassi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.